You might like
#Cantargia presents positive results for nadunolimab at AACR 2023 including new clinical data in pancreatic cancer #canta
$TRVX: Targovax ASA has agreed to the terms and conditions for a convertible bond facility with Atlas Special Opportunities which will secure financing of up to gross NOK 300 million over three years.
Vaultavo Introduces Biometric Smart Card Based Crypto Custody Solution theasianbanker.com/mediafeed-news…
BNP Paribas attracts and onboards new premium customers in the first large-scale commercial launch of the #biometric payment card 💳 thalesgroup.com/en/markets/dig…
Gyros Protein Technologies @GyrosProteinTec installed a Symphony® X instrument in #Oncopeptides AB (publ) @oncopeptides_ab lab in Stockholm, Solna. gyrosproteintechnologies.com/peptides/produ…
Cantargia announces appointment of Patrik Renblad as Chief Financial Officer dlvr.it/ShmwgB
#Cantargia completes toxicity study of #CAN10 antibody The CAN10 antibody was found to be well tolerated when administered over six weeks in the trial. clinicaltrialsarena.com/news/cantargia…
The answer is "Crypto #Biometric Contactless Payment cards" with decentralized Wallets - In short, your fingerprint is your private key, and all digital assets are stored on your 100% own payment card.
Convego® YOU Biometric Payment Card – Giesecke + Devrient Convego® YOU replaces traditional PINs by making the most unique of all human attributes – the fingerprint – central to the relationship, with a sensor on the card itself. #Giesecke+Devrient #FPC #FING
G+D means creating tomorrow’s card and digital payment products, services and solutions. G+D Convego YOU, the biometric payment card that knows YOU. This biometric card is the newest member to our cards family. #fing #FPC youtube.com/watch?v=zeDH7T…
G+D means creating tomorrow’s card and digital payment products, services and solutions. G+D Convego YOU, the biometric payment card that knows YOU. This biometric card is the newest member to our cards family. #fing #FPC youtube.com/watch?v=zeDH7T…
#Cantargia $canta is a clinical-stage biotechnology company based in Sweden. It is developing two assets against IL1RAP, CAN04 and CAN10. CAN04 is being studied in several solid tumours edisongroup.com/equity/cantarg…
edisongroup.com
Cantargia
Cantargia
Carnegie ser positivt på Cantargia’s nya säkerhetsdata för CAN10 - upprepar riktkurs 20kr placera.se/placera/telegr…
United States Trends
- 1. South Carolina 32K posts
- 2. Bama 10.8K posts
- 3. #EubankBenn2 27.8K posts
- 4. Mateer 2,598 posts
- 5. Ty Simpson 2,371 posts
- 6. Texas A&M 31.5K posts
- 7. Oklahoma 19.3K posts
- 8. Arbuckle N/A
- 9. #UFC322 24.9K posts
- 10. Beamer 9,171 posts
- 11. Ryan Williams 1,504 posts
- 12. Camilo 8,553 posts
- 13. Heisman 9,214 posts
- 14. Daniel Hill N/A
- 15. #Sooners 1,593 posts
- 16. Makai Lemon N/A
- 17. Georgia Tech 2,161 posts
- 18. Michigan 43.9K posts
- 19. Aggies 9,225 posts
- 20. #RollTide 2,519 posts
You might like
-
Biometric Update
@BiometricUpdate -
Bentyl
@Bentyl50 -
dotnfc
@dotnfc -
EDDA
@NSSA87 -
Motorola Solutions
@MotoSolutions -
Taz
@Tazzen76 -
ILW.COM
@ilwcom -
GabPow🇸🇪
@GabPow1 -
HansH
@Bassobike2 -
Steffan J.
@SteffanJJensen -
Te⚡️la-Tar⚡️an
@jackiney -
ilooklock
@VaileZhang -
E-Adde🇸🇪🇺🇦
@MrAdde -
Álvaro Trigo 🐦🔥
@IMAC2 -
fpc
@FingerprintCard
Something went wrong.
Something went wrong.